CAPITAL IMPACT ADVISORS, LLC Vir Biotechnology, Inc. Transaction History

CAPITAL IMPACT ADVISORS, LLC portfolio value:

$360,000
portfolio value

CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:

-24.30%
quarter

Vir Biotechnology, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +9.37% 1.13K shares 53K $19.28 13.19K
Q2 2022 share Decrease -21.64% -3.33K shares -89K $25.47 12.06K
Q1 2022 share Increase 0.00% 15.39K shares 396K $25.72 15.39K